NCT04184622 ), and in SURPASS-2 it outperformed semaglutide on glucose and weight endpoints in type 2 diabetes ( Fras et al., NEJM 2021 )
Rani notes that its a good idea to avoid long or distant travel immediately after starting GLP-1 meds
BPC-157 human evidence is limited Most BPC-157 studies included in recent reviews are preclinical
Benefits Of Microdosing Tirzepatide Fewer Side Effects During Dose Escalation Slower titration reduces the intensity of gastrointestinal effects for many patients, which explains why clinicians experiment with smaller steps when early nausea threatens continuation
An effective strategy for cancer prevention is a multifaceted approach that targets different pathways involved in cancer initiation and progression
Sarwer DB, Spitzer JC, Wadden TA, Rosen RC, Mitchell JE, Lancaster K, et al